Wednesday, July 8, 2026

pharma · Duchenne Muscular Dystrophy · Duchenne Muscular Dystrophy (DMD) · TRDA

Entrada Therapeutics

Entrada Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Boston, USA HQ
2016 Founded
201 Employees
Public company Type
TRDA · NYSE Ticker
Company details
Status
Public
HQ
Boston, USA
Founded
2016
Employees
201
Programs
4
Drugs
4
Patents
5
Intelligence · Clinical Trials

Entrada Therapeutics clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Entrada Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.

Entrada Therapeutics trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Entrada Therapeutics.

  1. SODIUM CHLORIDE, ENTR-601-45 — Phase 2

    Clinical update
  2. ENTR-601-44, SODIUM CHLORIDE — Phase 2

    Clinical update
  3. ENTR-601-45 — Phase 2

    Clinical update
  4. ENTR-601-44 — Phase 2

    Clinical update

Trial registry

4 studies